Huang F - Search Results

1

A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study.

Liu H, Xuan L, Lin R, Deng L, Fan Z, Nie D, Li X, Liang X, Xu D, Zhang Y, Xu N, Ye J, Jin H, Lin D, Ma L, Sun J, Huang F, Liu Q. Liu H, et al. Among authors: huang f. Leukemia. 2021 Jul;35(7):2054-2063. doi: 10.1038/s41375-020-01090-4. Epub 2020 Nov 17. Leukemia. 2021. PMID: 33204013

2

[Glivec in combination with HA regimen for treatment of 20 patients with Ph chromosome positive acute leukemia].

Meng FY, Zheng WY, Liu XL, Song LL, Xu B, Zhang Y, Huang F. Meng FY, et al. Among authors: huang f. Ai Zheng. 2003 Aug;22(8):840-3. Ai Zheng. 2003. PMID: 12917031 Chinese.

3

[Modified FLAG regimen in the management of refractory acute myeloid leukemia].

Yang LJ, Meng FY, Xu B, Liu XL, Zheng WY, Zhang Y, Huang F, Xu D, Sun J, Liu QF. Yang LJ, et al. Among authors: huang f. Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):1054-5. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14559692 Clinical Trial. Chinese.

4

[STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia].

Meng FY, Zheng WY, Liu XL, Xu B, Song LL, Zhang Y, Huang F. Meng FY, et al. Among authors: huang f. Di Yi Jun Yi Da Xue Xue Bao. 2003 Nov;23(11):1149-50. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14625174 Chinese.

5

[Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].

Meng FY, Yang LJ, Xu B, Liu XL, Zheng WY, Zhang Y, Huang F, Sun J, Liu QF. Meng FY, et al. Among authors: huang f. Ai Zheng. 2003 Dec;22(12):1330-3. Ai Zheng. 2003. PMID: 14693062 Clinical Trial. Chinese.

6

[Therapeutic effects of chemotherapeutic regimen with pirarubicin for adult high-risk acute leukemia].

Huang F, Meng FY, Xue B, Liu XL, Zhang Y, Ye CX, Zhang X. Huang F, et al. Di Yi Jun Yi Da Xue Xue Bao. 2004 Jul;24(7):768-70. Di Yi Jun Yi Da Xue Xue Bao. 2004. PMID: 15257898 Chinese.

7

[Effects of graft compositions on hematopoietic reconstitution and graft-versus-host disease in related donor peripheral blood stem cell transplantation].

Zhan Y, Yi ZS, Wei YQ, Huang F, Zhang YM, Fan ZP, Feng R. Zhan Y, et al. Among authors: huang f. Zhonghua Xue Ye Xue Za Zhi. 2008 May;29(5):333-6. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18844073 Chinese.

8

Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.

Liu QF, Xu XJ, Chen YK, Sun J, Zhang Y, Fan ZP, Xu D, Jiang QL, Wei YQ, Huang F, Feng R, Liu XL, Xu B, Meng FY. Liu QF, et al. Among authors: huang f. Ann Hematol. 2011 Mar;90(3):331-41. doi: 10.1007/s00277-010-1081-3. Epub 2010 Sep 25. Ann Hematol. 2011. PMID: 20872002 Clinical Trial.

9

Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.

Xuan L, Wu X, Zhang Y, Fan Z, Ling Y, Huang F, Zhang F, Zhai X, Liu Q. Xuan L, et al. Among authors: huang f. J Transl Med. 2011 Dec 15;9:215. doi: 10.1186/1479-5876-9-215. J Transl Med. 2011. PMID: 22171570 Free PMC article.

10

[The outcome and safety of mesenchymal stem cells from bone marrow of a third party donor in treatment of secondary poor graft function following allogeneic hematopoietic stem cell transplantation].

Liu XD, Fan ZP, Peng YW, Huang F, Jiang QL, Zhang X, Yu GP, Zhao J, Sun J, Xiang P, Liu QF. Liu XD, et al. Among authors: huang f. Zhonghua Xue Ye Xue Za Zhi. 2012 Feb;33(2):98-102. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22730656 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,368 results

Search Page

Filters